Logo image of BYND

BEYOND MEAT INC (BYND) Stock Fundamental Analysis

USA - NASDAQ:BYND - US08862E1091 - Common Stock

2.83 USD
+0.06 (+2.17%)
Last: 9/19/2025, 8:00:02 PM
2.85 USD
+0.02 (+0.71%)
After Hours: 9/19/2025, 8:00:02 PM
Fundamental Rating

1

Taking everything into account, BYND scores 1 out of 10 in our fundamental rating. BYND was compared to 89 industry peers in the Food Products industry. BYND may be in some trouble as it scores bad on both profitability and health. BYND is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BYND has reported negative net income.
BYND had a negative operating cash flow in the past year.
In the past 5 years BYND always reported negative net income.
BYND had a negative operating cash flow in each of the past 5 years.
BYND Yearly Net Income VS EBIT VS OCF VS FCFBYND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

BYND's Return On Assets of -22.20% is on the low side compared to the rest of the industry. BYND is outperformed by 78.65% of its industry peers.
Industry RankSector Rank
ROA -22.2%
ROE N/A
ROIC N/A
ROA(3y)-33.92%
ROA(5y)-25.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYND Yearly ROA, ROE, ROICBYND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

The Gross Margin of BYND (10.57%) is worse than 67.42% of its industry peers.
BYND's Gross Margin has declined in the last couple of years.
BYND does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.31%
GM growth 5Y-17.54%
BYND Yearly Profit, Operating, Gross MarginsBYND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

BYND does not have a ROIC to compare to the WACC, probably because it is not profitable.
BYND has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BYND has more shares outstanding
BYND has a worse debt/assets ratio than last year.
BYND Yearly Shares OutstandingBYND Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BYND Yearly Total Debt VS Total AssetsBYND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -2.55, we must say that BYND is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BYND (-2.55) is worse than 84.27% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.55
ROIC/WACCN/A
WACC5.83%
BYND Yearly LT Debt VS Equity VS FCFBYND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

BYND has a Current Ratio of 3.29. This indicates that BYND is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.29, BYND belongs to the best of the industry, outperforming 85.39% of the companies in the same industry.
A Quick Ratio of 2.07 indicates that BYND has no problem at all paying its short term obligations.
BYND has a Quick ratio of 2.07. This is amongst the best in the industry. BYND outperforms 86.52% of its industry peers.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 2.07
BYND Yearly Current Assets VS Current LiabilitesBYND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

2

3. Growth

3.1 Past

BYND shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.66%, which is quite impressive.
Looking at the last year, BYND shows a decrease in Revenue. The Revenue has decreased by -5.17% in the last year.
The Revenue has been growing slightly by 1.85% on average over the past years.
EPS 1Y (TTM)34.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.53%
Revenue 1Y (TTM)-5.17%
Revenue growth 3Y-11.1%
Revenue growth 5Y1.85%
Sales Q2Q%-19.56%

3.2 Future

The Earnings Per Share is expected to grow by 14.55% on average over the next years. This is quite good.
BYND is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.16% yearly.
EPS Next Y21.58%
EPS Next 2Y17.32%
EPS Next 3Y13.08%
EPS Next 5Y14.55%
Revenue Next Year-13.59%
Revenue Next 2Y-6.7%
Revenue Next 3Y-3.84%
Revenue Next 5Y-1.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BYND Yearly Revenue VS EstimatesBYND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
BYND Yearly EPS VS EstimatesBYND Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BYND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BYND. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYND Price Earnings VS Forward Price EarningsBYND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BYND Per share dataBYND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

BYND's earnings are expected to grow with 13.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.32%
EPS Next 3Y13.08%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BYND!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEYOND MEAT INC

NASDAQ:BYND (9/19/2025, 8:00:02 PM)

After market: 2.85 +0.02 (+0.71%)

2.83

+0.06 (+2.17%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners43.96%
Inst Owner Change2.75%
Ins Owners4.56%
Ins Owner Change-1.39%
Market Cap216.92M
Analysts46.67
Price Target2.69 (-4.95%)
Short Float %42.57%
Short Ratio11.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.38%
Min EPS beat(2)-35.72%
Max EPS beat(2)-5.04%
EPS beat(4)1
Avg EPS beat(4)-19.53%
Min EPS beat(4)-46.83%
Max EPS beat(4)9.47%
EPS beat(8)1
Avg EPS beat(8)-13.6%
EPS beat(12)4
Avg EPS beat(12)-9.82%
EPS beat(16)4
Avg EPS beat(16)-24.85%
Revenue beat(2)0
Avg Revenue beat(2)-10.28%
Min Revenue beat(2)-10.39%
Max Revenue beat(2)-10.16%
Revenue beat(4)0
Avg Revenue beat(4)-5.79%
Min Revenue beat(4)-10.39%
Max Revenue beat(4)-1%
Revenue beat(8)2
Avg Revenue beat(8)-3.22%
Revenue beat(12)3
Avg Revenue beat(12)-3.98%
Revenue beat(16)3
Avg Revenue beat(16)-3.92%
PT rev (1m)-8.93%
PT rev (3m)-8.93%
EPS NQ rev (1m)-7.5%
EPS NQ rev (3m)-25.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.19%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-12.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.72
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.13
EYN/A
EPS(NY)-1.44
Fwd EYN/A
FCF(TTM)-1.63
FCFYN/A
OCF(TTM)-1.44
OCFYN/A
SpS3.93
BVpS-8.83
TBVpS-8.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.2%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.57%
FCFM N/A
ROA(3y)-33.92%
ROA(5y)-25.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.31%
GM growth 5Y-17.54%
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.04%
Cap/Sales 4.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.29
Quick Ratio 2.07
Altman-Z -2.55
F-Score3
WACC5.83%
ROIC/WACCN/A
Cap/Depr(3y)98.2%
Cap/Depr(5y)297.95%
Cap/Sales(3y)7.98%
Cap/Sales(5y)14.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.53%
EPS Next Y21.58%
EPS Next 2Y17.32%
EPS Next 3Y13.08%
EPS Next 5Y14.55%
Revenue 1Y (TTM)-5.17%
Revenue growth 3Y-11.1%
Revenue growth 5Y1.85%
Sales Q2Q%-19.56%
Revenue Next Year-13.59%
Revenue Next 2Y-6.7%
Revenue Next 3Y-3.84%
Revenue Next 5Y-1.16%
EBIT growth 1Y49.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.28%
EBIT Next 3Y19.88%
EBIT Next 5Y19.24%
FCF growth 1Y40.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.17%
OCF growth 3YN/A
OCF growth 5YN/A